Type and Timing of Clinical Assessments. H&Y: modified Hoehn and Yahr... | Download Scientific Diagram
![Hoehn and Yahr Stating recommended scale for Parkinson Disease stating.... | Download Scientific Diagram Hoehn and Yahr Stating recommended scale for Parkinson Disease stating.... | Download Scientific Diagram](https://www.researchgate.net/publication/323104023/figure/fig1/AS:592502147014659@1518274928977/Hoehn-and-Yahr-Stating-recommended-scale-for-Parkinson-Disease-stating-Movement-Disorder.png)
Hoehn and Yahr Stating recommended scale for Parkinson Disease stating.... | Download Scientific Diagram
![Applied Sciences | Free Full-Text | Relationship between Amount of Daily Movement Measured by a Triaxial Accelerometer and Motor Symptoms in Patients with Parkinson's Disease Applied Sciences | Free Full-Text | Relationship between Amount of Daily Movement Measured by a Triaxial Accelerometer and Motor Symptoms in Patients with Parkinson's Disease](https://www.mdpi.com/applsci/applsci-07-00486/article_deploy/html/images/applsci-07-00486-g001.png)
Applied Sciences | Free Full-Text | Relationship between Amount of Daily Movement Measured by a Triaxial Accelerometer and Motor Symptoms in Patients with Parkinson's Disease
![Understanding Hoehn and Yahr – Adult and pediatric printable resources for speech and occupational therapists Understanding Hoehn and Yahr – Adult and pediatric printable resources for speech and occupational therapists](https://therapyinsights.com/wp-content/uploads/2021/12/understanding-hoehn-and-yahr.jpg)
Understanding Hoehn and Yahr – Adult and pediatric printable resources for speech and occupational therapists
![Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2016/09/clinical_staging_of_patients_with_parkinson.png)
Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY
![Frontiers | Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China Frontiers | Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China](https://www.frontiersin.org/files/Articles/446281/fnmol-12-00171-HTML/image_m/fnmol-12-00171-t002.jpg)
Frontiers | Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China
![Table 1 from Parkinson's disease biomarkers in peripheral blood T lymphocytes: identification through a proteomic approach | Semantic Scholar Table 1 from Parkinson's disease biomarkers in peripheral blood T lymphocytes: identification through a proteomic approach | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd856e6db4e4405042cd102ddfa62187e816943d/9-Table1-1.png)